CVRX INC. - COMMON STOCK

CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer

31 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire

CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

25 янв 2024 16:05:00 Источник Nasdaq GlobeNewswire

CVRx to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call on January 25th, 2024

11 янв 2024 16:30:00 Источник Nasdaq GlobeNewswire

CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results and Announces Nadim Yared Retirement Plans

08 янв 2024 08:30:00 Источник Nasdaq GlobeNewswire

CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference

27 дек 2023 16:30:00 Источник Nasdaq GlobeNewswire

CVRx receives FDA approval for expanded labeling of Barostim

26 дек 2023 08:05:00 Источник Nasdaq GlobeNewswire

CVRx to Present at the 35th Annual Piper Sandler Healthcare Conference

15 ноя 2023 16:21:43 Источник Nasdaq GlobeNewswire

CMS Increases Outpatient Payment for Barostim Procedure

03 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire

CVRx Reports Third Quarter 2023 Financial and Operating Results

26 окт 2023 16:15:00 Источник Nasdaq GlobeNewswire

CVRx to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call on October 26th, 2023

12 окт 2023 16:30:00 Источник Nasdaq GlobeNewswire

CVRx to Present at the Canaccord Genuity 43rd Annual Growth Conference

27 июл 2023 08:30:00 Источник Nasdaq GlobeNewswire

CVRx Reports Second Quarter 2023 Financial and Operating Results

25 июл 2023 16:15:00 Источник Nasdaq GlobeNewswire

CVRx to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call on July 25th, 2023

11 июл 2023 16:30:00 Источник Nasdaq GlobeNewswire

CVRx Set to Join Russell 2000 & 3000 Indexes

22 июн 2023 16:30:00 Источник Nasdaq GlobeNewswire

CVRx to Present at the William Blair 43rd Annual Growth Stock Conference

25 май 2023 08:30:00 Источник Nasdaq GlobeNewswire

CVRx Reports First Quarter 2023 Financial and Operating Results

27 апр 2023 16:15:00 Источник Nasdaq GlobeNewswire

CVRx to Report First Quarter 2023 Financial and Operating Results and Host Conference Call on April 27th, 2023

20 апр 2023 16:30:00 Источник Nasdaq GlobeNewswire

Totality of Evidence from BeAT-HF Study Shows CVRx’s Barostim Provides Long-term Benefits for Patients with Heart Failure

21 мар 2023 11:02:23 Источник Nasdaq GlobeNewswire

CVRx Reiterates Plans to Discuss the Preliminary Results from the Post-Market Phase of the BeAT-HF Trial at THT 2023 and Schedules a Conference Call

16 мар 2023 08:30:00 Источник Nasdaq GlobeNewswire

CVRx Reports Preliminary Results of the BeAT-HF Post-Market Randomized Clinical Trial

21 фев 2023 07:00:00 Источник Nasdaq GlobeNewswire